TAT Technologies Reports Second Quarter 2025 Results
Financial highlights for the second quarter of 2025:
-
Revenues increased by 18.0% to
$43.1 million compared to$36.5 million for the second quarter of 2024. For the first half of 2025 revenues increased by 20.7% to$85.2 million compared to$70.6 million in the first half of 2024. -
Gross profit increased by 35.6% to
$10.8 million compared to$8.0 million for the second quarter of 2024 (25.1% of revenues in Q2\25 compared to 21.9% of revenues in Q2\24). For the first half of 2025 gross profit increased by 38.1% to$20.8 million compared to$15.1 million in the first half of 2024 (24.4% of revenues in H1\25 compared to 21.3% of revenues in H1\24) -
Operating Income increased by 62.2% to
$4.4 million compared to$2.7 million for the second quarter of 2024, (10.3% of revenues in Q2\25 compared to 7.5% of revenues in Q2\24). For the first half of 2025 operating income increased by 74.1% to$8.6 million compared to$4.9 million in the first half of 2024 (10.1% of revenues in H1\25 compared to 7.0% of revenues in H1\24). -
Net Income increased by 31.5% to
$3.4 million compared to$2.6 million for the second quarter of 2024. For the first half of 2025 net income increased by 53.5% to$7.2 million compared to$4.7 million in the first half of 2024.Adjusted EBITDA increased by 39.2% to$6.1 million (14.0% of revenues) compared to$4.3 million (11.9% of revenues) for the second quarter of 2024. Adjusted EBITDA for the first half of 2025 increased by 47.1% to$11.8 million compared to$8.0 million in the first half of 2024 (13.9% of revenues in H1\25 compared to 11.4% in H1\24). -
Cash flow provided by operating activities for the three and six months ended
June 30, 2025 , was$6.9 million and$1.9 million , respectively, compared to cash flows used in operating activities of$(4.1) million and$(7.6) million for the three and six months endedJune 30, 2024 , respectively.
Mr.
"In addition to the double-digit revenue growth, the value of our LTA and backlog grew by approximately
With the growing LTA value and backlog, strong order intake, and the ramp up in MRO activity, we are confident in our ability to sustain growth and expand profit margins through 2026," concluded
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, the Company also presents Adjusted EBITDA. The adjustments to the Company's GAAP results are made with the intent of providing both management and investors with a more complete understanding of the Company's underlying operational results, trends and performance. Adjusted EBITDA is calculated as net income excluding the impact of: the Company's share in results of affiliated companies, share-based compensation, taxes on income, financial (expenses) income, net, and depreciation and amortization. Adjusted EBITDA, however, should not be considered as an alternative to net income and operating income for the period and may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles and may not be comparable to other similarly titled measures for other companies. See reconciliation of Adjusted EBITDA below.
About
We are a leading provider of solutions and services to the aerospace and defense industries. We operate four operational units: (i) original equipment manufacturing ("OEM") of heat transfer solutions and aviation accessories through our
TAT's activities in the area of OEM of heat transfer solutions and aviation accessories through TAT Israel primarily include the design, development and manufacture of (i) a broad range of heat transfer solutions, such as pre-coolers heat exchangers and oil/fuel hydraulic heat exchangers, used in mechanical and electronic systems on board commercial, military and business aircraft; (ii) environmental control and power electronics cooling systems installed on board aircraft and ground applications; and (iii) a variety of mechanical aircraft accessories and systems such as pumps, valves, and turbine power units.
TAT's activities in the area of MRO and OEM of heat transfer solutions include the MRO of heat transfer components and to a lesser extent, the manufacturing of certain heat transfer solutions. TAT's Limco subsidiary operates a
TAT's activities in the area of MRO services for aviation components include the MRO of APUs and landing gear. TAT's Piedmont subsidiary operates an
TAT's activities in the area of jet engine overhaul through its Turbochrome facility includes the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps.
Contact:
Mr.
Director of IR
erany@tat-technologies.com
Safe Harbor for Forward-Looking Statements
This press release and/or this report contains "forward-looking statements" within the meaning of
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|
|||
|
|
|||
|
J une 30, |
|
|
|
2025 |
|
2024 |
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
Cash and cash equivalents |
$ 43,126 |
|
$ 7,129 |
|
Short-term bank deposits |
57 |
|
- |
|
Accounts receivable, net of allowance for credit losses of
and |
32,266 |
|
29,697 |
|
Inventory |
76,414 |
|
68,540 |
|
Prepaid expenses and other current assets |
6,610 |
|
7,848 |
|
|
|
|
|
|
Total current assets |
158,473 |
|
113,214 |
|
|
|
|
|
|
NON-CURRENT ASSETS: |
|
|
|
|
Property, plant and equipment, net |
44,646 |
|
41,576 |
|
Operating lease right of use assets |
3,475 |
|
2,282 |
|
Intangible assets, net |
1,558 |
|
1,553 |
|
Investment in affiliates |
4,188 |
|
2,901 |
|
Funds in respect of employee rights upon retirement |
709 |
|
654 |
|
Deferred income taxes |
295 |
|
877 |
|
Restricted deposit |
291 |
|
305 |
|
|
|
|
|
|
Total non-current assets |
55,162 |
|
50,148 |
|
Total assets |
|
|
$ 163,362 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
Current maturities of long-term loans |
$ 2,088 |
|
$ 2,083 |
|
Short-term loans |
- |
|
4,350 |
|
Accounts payable |
15,564 |
|
12,158 |
|
Accrued expenses and other |
15,273 |
|
18,594 |
|
Current maturities of operating lease liabilities |
993 |
|
939 |
|
|
|
|
|
|
Total current liabilities |
33,918 |
|
38,124 |
|
|
|
|
|
|
NON-CURRENT LIABILITIES: |
|
|
|
|
Long-term loans |
10,310 |
|
10,938 |
|
Liability in respect of employee rights upon retirement |
1,098 |
|
986 |
|
Operating lease liabilities |
2,528 |
|
1,345 |
|
|
|
|
|
|
Total non-current liabilities |
13,936 |
|
13,269 |
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES (NOTE 4) |
- |
|
- |
|
Total liabilities |
47,854 |
|
51,393 |
|
|
|
|
|
|
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
|
|||
SHAREHOLDERS' EQUITY: |
|
|
|
Ordinary shares of
Authorized: 15,000,000 shares at |
- |
|
- |
Additional paid-in capital |
135,578 |
|
89,697 |
|
(2,088) |
|
(2,088) |
Accumulated other comprehensive income (loss) |
600 |
|
(76) |
Retained earnings |
31,691 |
|
24,436 |
Total shareholders' equity |
165,781 |
|
111,969 |
|
|
|
|
Total liabilities and shareholders' equity |
$ 213,635 |
|
$ 163,362 |
|
|
|
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|
|
|
||||
|
Three months ended |
|
Six months ended |
||||
|
|
||||||
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues: |
|
|
|
|
|
|
|
Products |
$ 12,463 |
|
$ 11,732 |
|
|
|
$ 23,667 |
Services |
30,641 |
|
24,793 |
|
60,059 |
|
46,946 |
|
43,104 |
|
36,525 |
|
85,246 |
|
70,613 |
|
|
|
|
|
|
|
|
Cost of goods: |
|
|
|
|
|
|
|
Products |
9,112 |
|
7,673 |
|
17,443 |
|
16,659 |
Services |
23,167 |
|
20,868 |
|
47,024 |
|
38,904 |
|
32,279 |
|
28,541 |
|
64,467 |
|
55,563 |
Gross profit |
10,825 |
|
7,984 |
|
20,779 |
|
15,050 |
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
Research and development, net |
240 |
|
343 |
|
564 |
|
620 |
Selling and marketing |
2,185 |
|
1,993 |
|
4,113 |
|
3,653 |
General and administrative |
3,965 |
|
2,916 |
|
7,497 |
|
6,225 |
Other income |
- |
|
(2) |
|
- |
|
(390) |
|
6,390 |
|
5,250 |
|
12,174 |
|
10,108 |
Operating income |
4,435 |
|
2,734 |
|
8,605 |
|
4,942 |
|
|
|
|
|
|
|
|
Interest expenses |
(324) |
|
(413) |
|
(659) |
|
(763) |
Other financial income (expenses), net |
(776) |
|
106 |
|
(499) |
|
7 |
Income before taxes on income (taxes benefit) |
3,335 |
|
2,427 |
|
7,447 |
|
4,186 |
|
|
|
|
|
|
|
|
Provision for taxes on income (taxes benefit) |
211 |
|
44 |
|
803 |
|
(109) |
Profit before share of equity investment |
3,124 |
|
2,383 |
|
6,644 |
|
4,295 |
|
|
|
|
|
|
|
|
Share in profits of equity investment of affiliated companies |
318 |
|
234 |
|
611 |
|
432 |
Net income |
$ 3,442 |
|
$ 2,617 |
|
$ 7,255 |
|
$ 4,727 |
|
|
|
|
|
|
|
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||||
|
|||||||
|
|
|
|
|
|
|
|
Earnings per share |
|
|
|
|
|
|
|
Basic |
|
|
$ 0.26 |
|
|
|
$ 0.46 |
Diluted |
|
|
$ 0.25 |
|
|
|
$ 0.44 |
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding |
|
|
|
|
|
|
|
Basic |
11,447,986 |
|
10,394,654 |
|
11,196,992 |
|
10,386,859 |
Diluted |
11,666,309 |
|
10,561,420 |
|
11,409,488 |
|
10,722,153 |
|
|
|
|
|
|
|
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME |
|
|||||||
|
|
|||||||
|
Three Months Ended
|
|
Six Months Ended
|
|
||||
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
|
Net income |
$ 3,442 |
|
$ 2,617 |
|
$ 7,255 |
|
$ 4,727 |
|
Other comprehensive income (loss), net |
|
|
|
|
|
|
|
|
Net unrealized losses from derivatives |
- |
|
- |
|
- |
|
(27) |
|
Change in foreign currency translation adjustments |
148 |
|
164 |
|
676 |
|
164 |
|
Total comprehensive income |
$ 3,590 |
|
$ 2,781 |
|
$ 7,931 |
|
$ 4,864 |
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY |
||||||||||||||||||
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
Share capital |
|
|
|
Accumulated |
|
|
|
|
|
|
|
|||||
|
|
Number of shares issued |
|
Amount |
|
Additional paid-in capital |
|
other comprehensive income (loss) |
|
|
|
Retained earnings |
|
Total equity |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BALANCE AT |
|
10,377,085 |
|
$ 3,140 |
|
$ 76,335 |
|
$ 27 |
|
$ (2,088) |
|
$ 13,269 |
|
$ 90,683 |
|
|||
CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 202 4 : |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Comprehensive income |
|
- |
|
- |
|
- |
|
137 |
|
- |
|
4,727 |
|
4,864 |
|
|||
Exercise of option |
|
49,109 |
|
12 |
|
(12) |
|
- |
|
- |
|
- |
|
- |
|
|||
Share based compensation |
|
- |
|
- |
|
189 |
|
- |
|
- |
|
- |
|
189 |
|
|||
BALANCE AT |
|
10,426,194 |
|
3,152 |
|
76,512 |
|
164 |
|
(2,088) |
|
17,996 |
|
95,736 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
BALANCE AT |
|
11,214,831 |
|
- |
|
89,697 |
|
(76) |
|
(2,088) |
|
24,436 |
|
111,969 |
|
|||
CHANGES DURING THE 6 MONTHS ENDED |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Comprehensive income |
|
- |
|
- |
|
- |
|
676 |
|
- |
|
7,255 |
|
7,931 |
|
|||
Exercise of option |
|
79,633 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
|||
Issuance of common shares on public offering, net of issuance costs of |
|
1,625,000 |
|
- |
|
39,415 |
|
- |
|
- |
|
- |
|
39,415 |
|
|||
Exercise of the underwriters' option on public offering, net of issuance costs of |
|
242,298 |
|
- |
|
5,953 |
|
- |
|
- |
|
- |
|
5,953 |
|
|||
Share based compensation |
|
- |
|
- |
|
513 |
|
- |
|
- |
|
- |
|
513 |
|
|||
BALANCE AT |
|
13,161,762 |
|
$ - |
|
$ 135,578 |
|
$ 600 |
|
$ (2,088) |
|
$ 31,691 |
|
$ 165,781 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY |
||||||||||||||||
|
||||||||||||||||
|
|
Share capital |
|
|
|
Accumulated |
|
|
|
|
|
|
|
|||
|
|
Number of shares issued |
|
Amount |
|
Additional paid-in capital |
|
other comprehensive income |
|
|
|
Retained earnings |
|
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE AT |
|
10,382,637 |
|
$ 3,141 |
|
$ 76,376 |
|
$ - |
|
$ (2,088) |
|
$ 15,379 |
|
$ 92,808 |
|
|
CHANGES DURING THE 3 MONTHS ENDED JUNE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
- |
|
- |
|
- |
|
164 |
|
- |
|
2,617 |
|
2,781 |
|
|
Exercise of option |
|
43,557 |
|
11 |
|
(12) |
|
- |
|
- |
|
- |
|
(1) |
|
|
Share based compensation |
|
- |
|
- |
|
148 |
|
- |
|
- |
|
- |
|
148 |
|
|
BALANCE AT |
|
10,426,194 |
|
3,152 |
|
76,512 |
|
164 |
|
(2,088) |
|
17,996 |
|
95,736 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BALANCE AT |
|
11,214,831 |
|
- |
|
89,919 |
|
452 |
|
(2,088) |
|
28,249 |
|
116,532 |
|
|
CHANGES DURING THE 3 MONTHS ENDED |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
- |
|
- |
|
- |
|
148 |
|
- |
|
3,442 |
|
3,590 |
|
|
Exercise of stock option |
|
79,633 |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
|
Issuance of common shares on public offering, net of issuance costs of |
|
1,625,000 |
|
- |
|
39,415 |
|
- |
|
- |
|
- |
|
39,415 |
|
|
Exercise of the underwriters' option on public offering, net of issuance costs of |
|
242,298 |
|
- |
|
5,953 |
|
- |
|
- |
|
- |
|
5,953 |
|
|
Share based compensation |
|
- |
|
- |
|
291 |
|
- |
|
- |
|
- |
|
291 |
|
|
BALANCE AT |
|
13,161,762 |
|
$ - |
|
$ 135,578 |
|
$ 600 |
|
$ (2,088) |
|
$ 31,691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
|||||||
|
Three Months Ended
|
|
Six M onths Ended
|
||||
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
Net income |
$ 3,442 |
|
$ 2,617 |
|
$ 7,255 |
|
$ 4,727 |
Adjustments to reconcile net income to net cash used in operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
1,208 |
|
1,431 |
|
2,513 |
|
2,805 |
Non-cash financial (income) expenses |
600 |
|
(276) |
|
508 |
|
(486) |
Change in allowance for credit losses |
75 |
|
40 |
|
25 |
|
40 |
Share in profits of equity investment of affiliated companies |
(318) |
|
(234) |
|
(611) |
|
(432) |
Share based compensation |
291 |
|
148 |
|
513 |
|
189 |
Gain on disposal of property, plant and equipment |
- |
|
(1) |
|
- |
|
(355) |
Deferred income taxes, net |
63 |
|
306 |
|
582 |
|
(103) |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
Decrease (increase) in trade accounts receivable |
882 |
|
(5,430) |
|
(2,594) |
|
(6,250) |
Decrease (increase) in prepaid expenses and other current assets |
1,697 |
|
(129) |
|
1,183 |
|
(283) |
Increase in inventory |
(3,434) |
|
(2,906) |
|
(7,295) |
|
(5,543) |
Increase (decrease) in trade accounts payable |
2,972 |
|
(209) |
|
3,406 |
|
(909) |
Decrease (increase) in accrued expenses and other |
(529) |
|
543 |
|
(3,571) |
|
(1,047) |
Net cash provided by (used in) operating activities |
6,949 |
|
(4,100) |
|
1,914 |
|
(7,647) |
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
Proceeds from sale of property and equipment |
- |
|
- |
|
- |
|
1,306 |
Purchase of property and equipment |
(3,305) |
|
(978) |
|
(6,167) |
|
(1,967) |
Net cash used in investing activities |
(3,305) |
|
(978) |
|
(6,167) |
|
(661) |
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
Repayments of long-term loans |
(516) |
|
(510) |
|
(1,087) |
|
(950) |
Proceeds from issuance of ordinary shares and exercise of the underwriters' option |
48,550 |
|
(1) |
|
48,550 |
|
- |
Issuance costs of ordinary shares and exercise of the underwriters' option |
(2,820) |
|
- |
|
(2,820) |
|
- |
Net change in short term loans from banks |
(10,719) |
|
4,668 |
|
(4,350) |
|
668 |
Net cash provided by (used in) financing activities |
34,495 |
|
4,157 |
|
40,293 |
|
(282) |
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents and restricted cash |
38,139 |
|
(921) |
|
36,040 |
|
(8,590) |
Cash and cash equivalents and restricted cash at beginning of period |
5,335 |
|
9,273 |
|
7,434 |
|
16,942 |
Cash and cash equivalents and restricted cash at the end of period |
$ 43,474 |
|
$ 8,352 |
|
$ 43,474 |
|
$ 8,352 |
|
|
|
|
|
|
|
|
Supplementary information on investing and financing activities not involving cash flows: |
|
|
|
|
|
|
|
Additions of operating lease right-of-use assets and operating lease liabilities |
|
|
$ 245 |
|
$ 1,835 |
|
$ 590 |
Reclassification between inventory and property, plant and equipment |
- |
|
- |
|
579 |
|
60 |
Unpaid issuance costs of ordinary shares and exercise of the underwriters' option |
362 |
|
- |
|
362 |
|
- |
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
Interest paid |
249 |
|
410 |
|
516 |
|
852 |
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP) (UNAUDITED)
( |
|||||||||||
|
|
|
|
||||||||
|
Three months ended |
|
Six months ended |
||||||||
|
|
|
|
||||||||
|
2025 |
|
|
2024 |
|
2025 |
|
2024 |
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
Net income |
$ 3,442 |
|
|
$ 2,617 |
|
$ 7,255 |
|
|
|
||
Adjustments: |
|
|
|
|
|
|
|
|
|
||
Share in results and sale of equity investment of affiliated companies |
(318) |
|
|
(234) |
|
(611) |
|
(432) |
|
||
Taxes on income (tax benefit) |
211 |
|
|
44 |
|
803 |
|
(109) |
|
||
Financial expenses, net |
1,100 |
|
|
306 |
|
1,158 |
|
756 |
|
||
Depreciation and amortization |
1,328 |
|
|
1,468 |
|
2,691 |
|
2,898 |
|
||
Share based compensation |
291 |
|
|
148 |
|
513 |
|
189 |
|
||
Adjusted EBITDA |
|
|
|
$ 4,349 |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
View original content:https://www.prnewswire.com/news-releases/tat-technologies-reports-second-quarter-2025-results-302526872.html
SOURCE